配子体
恶性疟原虫
疟疾
生物
青蒿素
疟原虫(生命周期)
病毒学
抗药性
寄生虫寄主
免疫学
微生物学
计算机科学
万维网
作者
Dina Coertzen,Janette Reader,Mariëtte van der Watt,Sindisiwe Nondaba,Liezl Gibhard,Lubbe Wiesner,Peter J. Smith,Sarah D’Alessandro,Donatella Taramelli,Hoi Shan Wong,Jan L. du Preez,Ronald Wai Keung Wu,Lyn‐Marié Birkholtz,Richard K. Haynes
摘要
The emergence of resistance toward artemisinin combination therapies (ACTs) by the malaria parasite Plasmodium falciparum has the potential to severely compromise malaria control. Therefore, the development of new artemisinins in combination with new drugs that impart activities toward both intraerythrocytic proliferative asexual and transmissible gametocyte stages, in particular, those of resistant parasites, is urgently required.
科研通智能强力驱动
Strongly Powered by AbleSci AI